Evolent Health Inc Cl A Com (EVH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,305 | -19,982 | -19,164 | -7,815 | -9,938 |
| Depreciation Amortization | 68,996 | 32,476 | 92,553 | 63,944 | 44,483 |
| Income taxes - deferred | -71,019 | -68,728 | -45,608 | -46,385 | 472 |
| Accounts receivable | -63,137 | 19,832 | -102,980 | -34,796 | 13,042 |
| Accounts payable and accrued liabilities | -12,732 | -13,585 | 13,165 | 5,936 | -823 |
| Other Working Capital | -61,106 | -41,344 | -104,441 | -122,268 | -96,638 |
| Other Operating Activity | 185,983 | 83,357 | 154,922 | 94,136 | 5,624 |
| Operating Cash Flow | $-7,320 | $-7,974 | $-11,553 | $-47,248 | $-43,778 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,900 | -9,055 | -38,361 | -27,618 | -17,744 |
| Net Acquisitions | -388,246 | -386,724 | -248,111 | -245,021 | -9,070 |
| Sale Of Investment | 799 | 786 | 5,552 | 4,175 | 4,175 |
| Other Investing Activity | 0 | 0 | 21,805 | 13,805 | 22,969 |
| Investing Cash Flow | $-403,347 | $-394,993 | $-259,115 | $-254,659 | $330 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 256,063 | 256,330 | 219,740 | 219,740 | 0 |
| Debt Repayment | -37,500 | -37,500 | N/A | N/A | 0 |
| Common Stock Issued | 4,654 | 1,581 | 4,452 | 3,280 | 309 |
| Dividend Paid | -8,535 | -3,651 | N/A | N/A | N/A |
| Other Financing Activity | 188,377 | 162,969 | -92,651 | -80,625 | -30,995 |
| Financing Cash Flow | $403,059 | $379,729 | $131,541 | $142,395 | $-30,686 |
| Beginning Cash Position | 215,158 | 215,158 | 354,942 | 354,942 | 354,942 |
| End Cash Position | 207,599 | 191,970 | 215,158 | 194,818 | 280,433 |
| Net Cash Flow | $-7,559 | $-23,188 | $-139,784 | $-160,124 | $-74,509 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,320 | -7,974 | -11,553 | -47,248 | -43,778 |
| Capital Expenditure | -15,900 | -9,055 | -38,361 | -27,618 | -17,744 |
| Free Cash Flow | -23,220 | -17,029 | -49,914 | -74,866 | -61,522 |